BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37844021)

  • 21. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    Machens A; Lorenz K; Weber F; Dralle H
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
    de Vries LH; Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJM; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
    Endocrine; 2018 Dec; 62(3):639-647. PubMed ID: 30128959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio.
    Xu P; Wu D; Liu X
    Endocrine; 2023 Jul; 81(1):107-115. PubMed ID: 36823341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
    Kazaure HS; Roman SA; Sosa JA
    Cancer; 2012 Feb; 118(3):620-7. PubMed ID: 21717441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.
    Prassas D; Kounnamas A; Cupisti K; Schott M; Knoefel WT; Krieg A
    Ann Surg Oncol; 2022 Apr; 29(4):2561-2569. PubMed ID: 34890024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR.
    Weber T; Lacroix J; Wörner S; Weckauf H; Winkler S; Hinz U; Schilling T; Frank-Raue K; Klar E; Knebel Doeberitz Mv Mv
    Int J Cancer; 2003 Jan; 103(1):126-31. PubMed ID: 12455065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma.
    Müller S; Poehnert D; Müller JA; Scheumann GW; Koch M; Lück R
    World J Surg; 2010 Jul; 34(7):1481-7. PubMed ID: 20162276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skip metastases in thyroid cancer leaping the central lymph node compartment.
    Machens A; Holzhausen HJ; Dralle H
    Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
    Bian F; Li C; Han D; Xu F; Lyu J
    Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
    Machens A; Lorenz K; Weber F; Dralle H
    Eur J Surg Oncol; 2021 Apr; 47(4):920-923. PubMed ID: 32962888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.
    Aubert S; Berdelou A; Gnemmi V; Behal H; Caiazzo R; D'herbomez M; Pigny P; Wemeau JL; Carnaille B; Renaud F; Bouchindhomme B; Leteurtre E; Perrais M; Pattou F; Do Cao C
    Virchows Arch; 2018 Mar; 472(3):461-468. PubMed ID: 29388012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
    Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.
    Qian K; Sun W; Guo K; Zheng X; Sun T; Chen L; Xiang J; Li D; Wu Y; Ji Q; Wang Z
    Eur J Surg Oncol; 2019 Jun; 45(6):1025-1032. PubMed ID: 30472214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
    Weber T; Amann K; Weckauf H; Lacroix J; Weitz J; Schönfuss T; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
    World J Surg; 2002 Feb; 26(2):148-52. PubMed ID: 11865340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.